Open AccessPossibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Author(s) -
А. С. Маркова,
В. Б. Матвеев
Publication year - 2017
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2017-13-3-132-139
Subject(s) - medicine , lenvatinib , everolimus , axitinib , cabozantinib , sorafenib , targeted therapy , renal cell carcinoma , nivolumab , oncology , sunitinib , kidney cancer , combination therapy , cancer , immunotherapy , hepatocellular carcinoma